Injectable, long-acting microparticle formulation for the delive

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514180, A61K 3158

Patent

active

045308403

ABSTRACT:
An anti-inflammatory agent containing microparticle composition prepared by a process, comprising (a) dissolving or dispersing an anti-inflammatory agent in a solvent and dissolving a biocompatible and biodegradable wall forming material in said solvent; (b) dispersing said solvent containing said anti-inflammatory agent and wall forming material in a continuous phase processing medium; (c) evaporating a portion of said solvent from said dispersion of step (b), thereby forming microparticles containing said anti-inflammatory agent in the suspension; and (d) extracting the remainder of the solvent from said microcapsules.

REFERENCES:
patent: 4066747 (1978-01-01), Capozza
patent: 4196188 (1980-04-01), Besins et al.
patent: 4267173 (1981-05-01), Draper et al.
patent: 4328204 (1982-05-01), Wasserman et al.
patent: 4374121 (1983-02-01), Cioca
patent: 4389330 (1983-06-01), Tice et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Injectable, long-acting microparticle formulation for the delive does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable, long-acting microparticle formulation for the delive, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable, long-acting microparticle formulation for the delive will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-634195

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.